Search Within

Alexander Meyer Lesokhin

Formats
  1. Meeting Abstract (252)
  2. Journal Article (103)
  3. Research Letter (11)
  4. Review (7)
  5. Correspondence (4)
  6. Book Section (2)
  7. Editorial (2)
Groups
  1. Center for Hematologic Malignancies (381)
  2. Department of Medicine (381)
  3. Hematologic Malignancies Research (381)
  4. Hematologic Malignancies, Division of (381)
  5. Myeloma (381)
  6. Survivorship Research (225)

More Groups

People
  1. Hani Hassoun (202)
  2. Heather Landau (187)
  3. Sergio Giralt (185)
  4. David Chung (175)
  5. Neha Korde (174)
  6. Sham Mailankody (170)

More People

Years
  1. 2025 (12)
  2. 2024 (52)
  3. 2023 (77)
  4. 2022 (51)
  5. 2021 (31)
  6. 2020 (18)

More Years

Publications
  1. Blood (140)
  2. Clinical Lymphoma, Myeloma and Leukemia (57)
  3. Journal of Clinical Oncology (41)
  4. Biology of Blood and Marrow Transplantation (13)
  5. Leukemia and Lymphoma (13)
  6. Blood Advances (12)

More Publications

Publishers
  1. American Society of Hematology (152)
  2. Elsevier Inc. (79)
  3. American Society of Clinical Oncology (41)
  4. Nature Publishing Group (26)
  5. American Association for Cancer Research (14)
  6. Taylor & Francis Group (13)

More Publishers

Results (381)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-term remissions after stopping pembrolizumab for relapsed or refractory multiple myeloma
    Journal Article

    Badros, A. Z.; Ma, N.; Rapoport, A. P.; Lederer, E.; Lesokhin, A. M.
    Blood Advances (2019)

    Fulltext@MSK | Save
  • Significant nationwide variability in the costs and hospital mortality rates of autologous stem cell transplantation for multiple myeloma: An analysis of the Nationwide Inpatient Sample database
    Journal Article

    Liu, Y.; Han, H.; Shah, G.; Giralt, S.; Landgren, C. O.; He, J.; Lesokhin, A. M.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Clinical responses and pharmacokinetics of MCARH171, a human-derived BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Final results of a phase I clinical trial
    Meeting Abstract

    Mailankody, S.; Ghosh, A.; Staehr, M.; Purdon, T. J.; Roshal, M.; Halton, E.; Diamonte, C.; Pineda, J.; Anant, P.; Bernal, Y.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • MRD-response driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m(2)) in combination with lenalidomide and dexamethasone
    Meeting Abstract

    Korde, N.; Mastey, D.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Smith, E. L.; Lendvai, N.; Hultcrantz, M.; Tavitian, E.; Salcedo, M.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Whole genome sequencing of extramedullary myeloma autopsy tumors reveals a genomic portrait at culmination of clonal convergence
    Meeting Abstract

    Yellapantula, V. D.; Rustad, E. H.; Glozdik, D.; Gundem, G.; Fan, J.; Medina, J.; Patel, A.; Patel, M.; Hultcrantz, M.; Peled, J. U.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Continuous mobile wearable bio-monitoring of newly diagnosed multiple myeloma patients undergoing initial chemotherapy
    Meeting Abstract

    Tavitian, E.; Mastey, D.; Salcedo, M.; Zarski, A.; Chansakul, A.; Diab, V.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Lendvai, N.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Depth of response and outcomes in patients with multiple myeloma undergoing autologous stem cell transplantation
    Meeting Abstract

    Shah, G. L.; Seier, K.; Devlin, S. M.; Chung, D. J.; Scordo, M.; Hultcrantz, M.; Korde, N.; Lendvai, N.; Lesokhin, A. M.; Mailankody, S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Intestinal microbiota composition is associated with minimal residual disease negativity in patients with multiple myeloma
    Meeting Abstract

    Pianko, M. J.; Devlin, S. M.; Littmann, E. R.; Chansakul, A.; Mastey, D.; Salcedo, M.; Fontana, E.; Ling, L. L.; Tavitian, E.; Slingerland, J. B.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Treatment outcomes in monoclonal immunoglobulin deposition disease (MIDD): A two center experience
    Meeting Abstract

    Pianko, M. J.; Tiutan, T.; Flynn, J.; Devlin, S. M.; Jaffer-Sathick, I.; Rossi, A. C.; Salvatore, S. P.; Landau, H. J.; Lendvai, N.; Smith, E. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A phase I, open-label study to evaluate the safety, pharmacokinetic, pharmacodynamic, and clinical activity of PF-06863135, a B-cell maturation antigen/CD3 bispecific antibody, in patients with relapsed/refractory advanced multiple myeloma
    Meeting Abstract

    Lesokhin, A. M.; Raje, N.; Gasparetto, C. J.; Walker, J.; Krupka, H. I.; Joh, T.; Taylor, C. T.; Jakubowiak, A.
    Blood (2018)

    Fulltext@MSK | Save